1. 2019 ARIA Care pathways for allergen immunotherapy. Issue 11 (15th July 2019) Authors: Bousquet, Jean; Pfaar, Oliver; Togias, Alkis; Schünemann, Holger J.; Ansotegui, Ignacio; Papadopoulos, Nikolaos G.; Tsiligianni, Ioanna; Agache, Ioana; Anto, Josep M.; Bachert, Claus; Bedbrook, Anna; Bergmann, Karl‐Christian; Bosnic‐Anticevich, Sinthia; Bosse, Isabelle; Brozek, Jan; Calderon, Moi... Journal: Allergy Issue: Volume 74:Issue 11(2019) Page Start: 2087 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A common language to assess allergic rhinitis control: results from a survey conducted during EAACI 2013 Congress. Issue 1 (27th October 2015) Authors: Hellings, Peter W.; Muraro, Antonella; Fokkens, Wytske; Mullol, Joaquim; Bachert, Claus; Canonica, G. Walter; Price, David; Papadopoulos, Nikos; Scadding, Glenis; Rasp, Gerd; Demoly, Pascal; Murray, Ruth; Bousquet, Jean Journal: Clinical and translational allergy Issue: Volume 5:Issue 1(2015) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A common language to assess allergic rhinitis control: results from a survey conducted during EAACI 2013 Congress. Issue 1 (December 2015) Authors: Hellings, Peter; Muraro, Antonella; Fokkens, Wytske; Mullol, Joaquim; Bachert, Claus; Canonica, G.; Price, David; Papadopoulos, Nikos; Scadding, Glenis; Rasp, Gerd; Demoly, Pascal; Murray, Ruth; Bousquet, Jean Journal: Clinical and translational allergy Issue: Volume 5:Issue 1(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A new allergic rhinitis therapy (MP29-02*) provides nasal and ocular symptom relief days faster than current firstline monotherapies. Issue 4 (December 2015) Authors: Hellings, Peter; Bachert, Claus; Mösges, Ralph; Scadding, Glenis; Munzel, Ullrich; Fokkens, Wytske Journal: Clinical and translational allergy Issue: Volume 5:Issue 4(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A new allergic rhinitis therapy (MP29‐02*) provides nasal and ocular symptom relief days faster than current firstline monotherapies. Issue 4 (26th June 2015) Authors: Hellings, Peter; Bachert, Claus; Mösges, Ralph; Scadding, Glenis; Munzel, Ullrich; Fokkens, Wytske Journal: Clinical and translational allergy Issue: Volume 5:Issue 4(2015)supplement 4 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. A new efficacy parameter (complete/near complete symptom relief) in allergic rhinitis management: results with a new therapy MP29‐02*. (16th July 2013) Authors: Bousquet, Jean; Scadding, Glenis; Price, David; Hellings, Peter; Fokkens, Wytske; Munzel, Ullrich; Bachert, Claus Journal: Clinical and translational allergy Issue: Volume 3(2013)supplement 2 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. A new intranasal therapy (MP29-02*) is more effective than current firstline therapy regardless of season, symptom or severity. Issue 4 (December 2015) Authors: Bachert, Claus; Fokkens, Wytske; Hellings, Peter; Scadding, Glenis; Munzel, Ullrich; Mullol, Joaquim Journal: Clinical and translational allergy Issue: Volume 5:Issue 4(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. A new intranasal therapy (MP29‐02*) is more effective than current firstline therapy regardless of season, symptom or severity. Issue 4 (26th June 2015) Authors: Bachert, Claus; Fokkens, Wytske; Hellings, Peter; Scadding, Glenis; Munzel, Ullrich; Mullol, Joaquim Journal: Clinical and translational allergy Issue: Volume 5:Issue 4(2015)supplement 4 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. A new therapy (MP29‐02*) effectively controls nasal symptoms of seasonal allergic rhinitis irrespective of severity. (16th July 2013) Authors: Scadding, Glenis; Price, David; Bousquet, Jean; Hellings, Peter; Fokkens, Wytske; Munzel, Ullrich; Bachert, Claus Journal: Clinical and translational allergy Issue: Volume 3(2013)supplement 2 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. A new therapy (MP29‐02*) effectively targets the entire seasonal allergic rhinitis symptom complex. (16th July 2013) Authors: Price, David; Bousquet, Jean; Bachert, Claus; Fokkens, Wytske; Scadding, Glenis; Munzel, Ullrich; Hellings, Peter Journal: Clinical and translational allergy Issue: Volume 3(2013)supplement 2 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗